CLOV vs TXG
Clover Health Investments Corp (CLOV) versus 10X Genomics Inc (TXG) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
10X Genomics Inc (TXG) is a health information services company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported TXG revenue for 2024-12-31 was $610.8M. Net income was -$182.6M. Revenue was down 1.3% from 2023-12-31 to 2024-12-31. TXG currently screens at market cap $4.08B.
CLOV currently screens at market cap $1.55B. TXG currently screens at market cap $4.08B.
Not investment advice. Open the CLOV and TXG stock pages for the full models.
Not investment advice.